Amgen logo

Senior Principal Scientist, Skin Biology and Inflammation

Amgen

South San Francisco, CA; Thousand Oaks, CAOnsitePosted 5 days ago$170,568.65 - $230,769.35/year
Full TimeSenior LevelResearch & ScientistPharmaceutical
Original posting ↗

Summary

In this vital role you will serve as a Senior Scientific leader in skin biology, shaping therapeutic hypotheses, programs, and capabilities across Inflammation Research. You will connect rigorous experimental biology with human data, computation, AI, automation, and emerging technologies to accelerate high-quality decisions from target discovery through early development.

Job description

Key Responsibilities

  • Provide scientific leadership for discovery programs, technology platforms, or strategic initiatives focused on skin biology and inflammatory disease.
  • Define compelling, human-biology-driven hypotheses and translate them into integrated experimental and computational strategies for target identification, validation, patient segmentation, and differentiated therapeutic approaches.
  • Bring deep expertise in keratinocyte biology, stem cells, stromal and fibroblast biology, epithelial-neuro-immune interactions, skin inflammation, tissue remodeling, barrier biology, and/or diseases of the skin.
  • Design, direct, and interpret complex studies using relevant human tissues and advanced preclinical systems, which may include primary cells, organotypic cultures, co-culture systems, spatial and single-cell approaches, perturbational biology, and disease-relevant in vivo models.
  • Continuously apply AI-enabled, computational, agentic, and data-science approaches to synthesize evidence, generate mechanistic insights, prioritize experiments, and improve the speed and quality of scientific decision-making.
  • Partner with computational scientists, engineers, automation experts, translational scientists, human geneticists, clinicians, and project teams to develop integrated datasets and predictive biological models.
  • Identify, evaluate, and implement emerging technologies that materially improve how skin biology is studied, including next-generation tissue models, imaging, multi-omics, high-content phenotyping, functional genomics, and scalable experimental platforms.
  • Guide program strategy, milestone definition, experimental prioritization, risk assessment, and resolution of complex scientific issues.
  • Be accountable for scientific quality and delivery against longer-term objectives.
  • Influence project, departmental, and broader functional strategy by recognizing external scientific and technology trends and translating them into actionable opportunities.
  • Lead and contribute to cross-functional teams, creating clarity in an evolving environment and connecting expertise across the organization to deliver results.
  • Coach and provide scientific and technical guidance to colleagues across the function, while fostering an inclusive, connected, curious, and high-performing research culture.
  • Communicate scientific strategy, evidence, uncertainty, and recommendations effectively to project teams, senior leaders, governance bodies, and external scientific audiences.
  • Build external scientific eminence through influential collaborations, conference participation, publications, patents, and other reviewed scientific or technical outputs.

Basic Qualifications

  • Doctorate degree PhD OR PharmD OR MD [and relevant post-doc where applicable] and 3 years of relevant experience OR Master’s degree and 6 years of relevant experience OR Bachelor’s degree and 8 years of relevant experience

Preferred Qualifications

  • Deep expertise in keratinocyte biology, stromal or fibroblast biology, skin inflammation, epithelial-immune crosstalk, wound repair, tissue remodeling, and/or inflammatory diseases of the skin.
  • Strong record of applying human tissues, disease-relevant cellular systems, organotypic models, spatial biology, single-cell methods, imaging, omics, functional genomics, or perturbational approaches to define mechanisms.
  • Demonstrated experience using AI-enabled tools, machine learning, computational biology, agentic research workflows, advanced analytics, or data integration to generate and test biological hypotheses.
  • Ability to identify where technology can create a step change in biological understanding, then build partnerships and workflows that convert promising concepts into robust capabilities.
  • Experience advancing drug discovery programs and understanding how target biology connects to modality, biomarkers, translational strategy, clinical differentiation, and portfolio value.
  • Evidence of scientific influence beyond an immediate team, such as cross-functional leadership, external collaborations, invited presentations, senior authorship, patents, or other recognized contributions.
  • Excellent written and verbal communication skills, including the ability to frame complex science, uncertainty, and recommendations for technical and senior leadership audiences.
  • Demonstrated excellence in project leadership and the ability to balance scientific rigor, strategic focus, urgency, adaptability, and operational execution.
  • Commitment to coaching others, sharing knowledge, and building a connected, inclusive, and inspiring environment in which colleagues can thrive.

Requirements

  • Doctorate degree PhD OR PharmD OR MD and 3 years of relevant experience OR Master’s degree and 6 years of relevant experience OR Bachelor’s degree and 8 years of relevant experience
  • Deep expertise in keratinocyte biology, stromal or fibroblast biology, skin inflammation, epithelial-immune crosstalk, wound repair, tissue remodeling, and/or inflammatory diseases of the skin
  • Strong record of applying human tissues, disease-relevant cellular systems, organotypic models, spatial biology, single-cell methods, imaging, omics, functional genomics, or perturbational approaches to define mechanisms
  • Demonstrated experience using AI-enabled tools, machine learning, computational biology, agentic research workflows, advanced analytics, or data integration to generate and test biological hypotheses
  • Ability to identify where technology can create a step change in biological understanding, then build partnerships and workflows that convert promising concepts into robust capabilities
  • Experience advancing drug discovery programs and understanding how target biology connects to modality, biomarkers, translational strategy, clinical differentiation, and portfolio value
  • Evidence of scientific influence beyond an immediate team, such as cross-functional leadership, external collaborations, invited presentations, senior authorship, patents, or other recognized contributions
  • Excellent written and verbal communication skills, including the ability to frame complex science, uncertainty, and recommendations for technical and senior leadership audiences
  • Demonstrated excellence in project leadership and the ability to balance scientific rigor, strategic focus, urgency, adaptability, and operational execution
  • Commitment to coaching others, sharing knowledge, and building a connected, inclusive, and inspiring environment in which colleagues can thrive

Benefits

  • Retirement and Savings Plan
  • Medical, Dental & Vision
  • Life and Disability Insurance
  • Flexible Spending Accounts
  • Discretionary Annual Bonus
  • Stock-based Long-term Incentives
  • Time-off Plans
  • Flexible Work Models

Company overview

Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.